{
    "company_name": "Verrica Pharmaceuticals Inc.",
    "file_name": "e1edf72618e9d6ae2e72bb3ac7a9ddc15240e4ef",
    "data_points": [
        {
            "company_name": "Verrica Pharmaceuticals Inc.",
            "industry": "Healthcare",
            "metric_type": "Active patient count (registered patients)",
            "metric_src_pdf_page": [
                5,
                6,
                7,
                10,
                11,
                12
            ]
        },
        {
            "company_name": "Verrica Pharmaceuticals Inc.",
            "industry": "Healthcare",
            "metric_type": "R&D pipeline (number of therapies in phases)",
            "metric_src_pdf_page": [
                5,
                10,
                11,
                12,
                20,
                23
            ]
        },
        {
            "company_name": "Verrica Pharmaceuticals Inc.",
            "industry": "Healthcare",
            "metric_type": "Healthcare plan memberships (if applicable)",
            "metric_src_pdf_page": [
                5,
                18
            ]
        },
        {
            "company_name": "Verrica Pharmaceuticals Inc.",
            "industry": "Healthcare",
            "metric_type": "Value of medical equipment (balance sheet)",
            "metric_src_pdf_page": [
                4,
                5,
                6
            ]
        },
        {
            "company_name": "Verrica Pharmaceuticals Inc.",
            "industry": "Healthcare",
            "metric_type": "Number of healthcare professionals on staff",
            "metric_src_pdf_page": [
                4,
                5
            ]
        },
        {
            "company_name": "Verrica Pharmaceuticals",
            "industry": "Healthcare",
            "metric_type": "Number of healthcare professionals on staff",
            "metric_src_pdf_page": [
                29,
                30,
                31,
                32,
                33,
                34,
                35,
                36,
                37,
                38,
                39,
                40,
                41,
                42,
                43,
                44,
                45,
                46,
                47
            ]
        },
        {
            "company_name": "Company X",
            "industry": "Healthcare",
            "metric_type": "Number of hospital beds at year-end",
            "metric_src_pdf_page": [
                49,
                50,
                51
            ]
        },
        {
            "company_name": "Verrica Pharmaceuticals Inc.",
            "industry": "Dermatology therapeutics",
            "metric_type": "Number of hospital beds at year-end",
            "metric_src_pdf_page": [
                75,
                79,
                83
            ]
        },
        {
            "company_name": "Verrica Pharmaceuticals Inc.",
            "industry": "Dermatology therapeutics",
            "metric_type": "Active patient count (registered patients)",
            "metric_src_pdf_page": [
                75,
                79,
                83
            ]
        },
        {
            "company_name": "Verrica Pharmaceuticals Inc.",
            "industry": "Healthcare",
            "metric_type": "R&D pipeline (number of therapies in phases)",
            "metric_src_pdf_page": [
                100,
                101,
                102,
                107,
                108
            ]
        }
    ],
    "events": [
        {
            "event_type": "has_new_product_launches",
            "events_src_pdf_page": [
                6,
                8,
                12,
                15,
                17
            ]
        },
        {
            "event_type": "has_rnd_investment_numbers",
            "events_src_pdf_page": [
                5,
                6,
                11,
                12,
                15
            ]
        },
        {
            "event_type": "has_leadership_changes",
            "events_src_pdf_page": [
                30,
                33,
                35
            ]
        },
        {
            "event_type": "has_new_product_launches",
            "events_src_pdf_page": [
                49,
                50
            ]
        },
        {
            "event_type": "has_guidance_updates",
            "events_src_pdf_page": [
                73,
                74
            ]
        },
        {
            "event_type": "has_new_product_launches",
            "events_src_pdf_page": [
                80,
                82
            ]
        },
        {
            "event_type": "has_rnd_investment_numbers",
            "events_src_pdf_page": [
                86,
                90
            ]
        },
        {
            "event_type": "mentions_new_risk_factors",
            "events_src_pdf_page": [
                105,
                106,
                109,
                111
            ]
        }
    ],
    "fin_metrics": [
        {
            "fin_metric_type": "total revenue",
            "fin_metrics_src_pdf_page": [
                2,
                14,
                20
            ]
        },
        {
            "fin_metric_type": "total liabilities",
            "fin_metrics_src_pdf_page": [
                4,
                6,
                7,
                8,
                9,
                20
            ]
        },
        {
            "fin_metric_type": "total liabilities",
            "fin_metrics_src_pdf_page": [
                29,
                30,
                31,
                32,
                33,
                34,
                35
            ]
        },
        {
            "fin_metric_type": "total liabilities",
            "fin_metrics_src_pdf_page": [
                49,
                51
            ]
        },
        {
            "fin_metric_type": "net income",
            "fin_metrics_src_pdf_page": [
                50,
                54
            ]
        },
        {
            "fin_metric_type": "net income",
            "fin_metrics_src_pdf_page": [
                85,
                94
            ]
        },
        {
            "fin_metric_type": "total revenue",
            "fin_metrics_src_pdf_page": [
                85,
                94
            ]
        },
        {
            "fin_metric_type": "return on assets (ROA)",
            "fin_metrics_src_pdf_page": [
                79,
                80
            ]
        },
        {
            "fin_metric_type": "net income",
            "fin_metrics_src_pdf_page": [
                110,
                120,
                121
            ]
        }
    ]
}